BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8554246)

  • 21. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
    Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensified conventional insulin treatment and neuropsychological impairment.
    Reichard P; Britz A; Rosenqvist U
    BMJ; 1991 Dec; 303(6815):1439-42. PubMed ID: 1773148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
    Duron F
    Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycaemia control in diabetes mellitus. Towards the normal profile?
    Zimmerman BR
    Drugs; 1994 Apr; 47(4):611-21. PubMed ID: 7516860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group.
    Diabetes Care; 1990 Apr; 13(4):427-33. PubMed ID: 2180661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia.
    Draelos MT; Jacobson AM; Weinger K; Widom B; Ryan CM; Finkelstein DM; Simonson DC
    Am J Med; 1995 Feb; 98(2):135-44. PubMed ID: 7847430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial.
    Diabetes Care; 1996 Mar; 19(3):195-203. PubMed ID: 8742561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive insulin treatment versus conventional regimen for adolescents with type 1 diabetes, benefits and risks.
    Al-Fifi SH
    Saudi Med J; 2003 May; 24(5):485-7. PubMed ID: 12847622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Feb; 46(2):271-86. PubMed ID: 9000705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A screening algorithm to identify clinically significant changes in neuropsychological functions in the Diabetes Control and Complications Trial. DCCT Research Group.
    J Clin Exp Neuropsychol; 1994 Apr; 16(2):303-16. PubMed ID: 8021316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis.
    Sämann A; Mühlhauser I; Bender R; Hunger-Dathe W; Kloos C; Müller UA
    Diabetes Care; 2006 Oct; 29(10):2196-9. PubMed ID: 17003292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient and family reflections on the use of subcutaneous insulin to prevent diabetes: a retrospective evaluation from a pilot prevention trial.
    Tercyak KP; Johnson SB; Schatz DA
    J Diabetes Complications; 1998; 12(5):279-86. PubMed ID: 9747645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helping diabetic patients avoid guilt when 'out of control'.
    McFarland K; Schell B; McCullough T
    Postgrad Med; 1989 Apr; 85(5):243-5, 248. PubMed ID: 2648371
    [No Abstract]   [Full Text] [Related]  

  • 39. The Diabetes Control and Complications Trial (DCCT): what every endocrinologist needs to know.
    Hadden DR
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):293-4. PubMed ID: 8187290
    [No Abstract]   [Full Text] [Related]  

  • 40. A practical guide to intensive insulin therapy.
    Campbell PJ; May ME
    Am J Med Sci; 1995 Jul; 310(1):24-30. PubMed ID: 7604835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.